Periodic Reporting for period 1 - SEXOGENIRI (Novel insights into sex-specific and oestrogen-dependent mechanisms in myocardial ischaemia/reperfusion injury)
Reporting period: 2021-06-01 to 2024-05-31
The overall aim of the proposed research is to study the role of biological sex in oxeiptosis during myocardial IRI. The main hypothesis is that there is a sex-based difference in the occurrence of oxeiptosis following IRI. It is further hypothesised that E2 plays a major role in this process, potentially involving the modulation of the components of mitochondrial fusion (Fig. 1). The specific aims are to:
1) assess and characterise oxeiptosis in male vs. female mice following IRI;
2) investigate the potential role of E2 in the induction of oxeiptosis in IRI;
3) assess the regulation of mitochondrial fusion proteins by E2 in oxeiptosis following IRI;
4) identify potential small-molecule candidates that can inhibit the occurrence of H2O2-induced oxeiptosis and preserve mitochondrial morphology and function;
5) assess the levels of selected candidates involved in oxeiptosis and mitochondrial fusion proteins in LV samples from adult male and female patients with ischaemic cardiomyopathy, thereby taking a translational approach.
As part of the dissemination and communication strategy, the research fellow and the supervisor authored and published the following review article in an open access journal:
Beikoghli Kalkhoran S, Kararigas G. Oestrogenic Regulation of Mitochondrial Dynamics. Int J Mol Sci 2022;23(3):1118